B-cell Lymphoma

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma Trial in Korea, Republic of, United States (Tiragolumab,

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Denver, Colorado
  • +12 more
Jan 19, 2023

B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)

Recruiting
  • B-cell Malignancy
  • +3 more
  • CTX110
  • Los Angeles, California
  • +27 more
May 6, 2022

Marginal Zone Lymphoma, B-cell Lymphoma Trial in Worldwide (ibrutinib)

Completed
  • Marginal Zone Lymphoma
  • B-cell Lymphoma
  • Tucson, Arizona
  • +24 more
Oct 8, 2019

B-Cell Lymphoma Trial in Worldwide (inotuzumab ozogamicin, Rituximab)

Completed
  • B-Cell Lymphoma
  • Birmingham, Alabama
  • +37 more
Feb 6, 2018

B-Cell Lymphoma, Hodgkin's Disease Trial in Atlanta (Thalidomide)

Terminated
  • B-Cell Lymphoma
  • Hodgkin's Disease
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
May 6, 2009

B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)

Completed
  • B-Cell Lymphoma
  • +2 more
  • VELCADE and rituximab
  • Los Angeles, California
  • +12 more
Feb 7, 2008